Dae Won Kim

Title: Dae Won Kim: Innovator in Pharmaceutical Composition

Introduction

Dae Won Kim is a notable inventor based in Chuncheon-si, South Korea. He has made significant contributions to the field of pharmaceutical compositions, particularly in the development of innovative treatments for various diseases. With a total of 2 patents, his work focuses on enhancing the efficiency of drug delivery systems.

Latest Patents

Dae Won Kim's latest patents include a protein transduction domain and a fusion compound containing the same. These innovations propose a more efficient method for delivering high-molecular-weight materials, such as proteins, into living bodies, including cells, tissues, or blood. The research led to the discovery of a GK1 peptide comprising 18 amino acids, which can be modified to improve its bonding capabilities. Additionally, he has developed a pharmaceutical composition for preventing or treating diseases using this fusion compound, oligonucleotide, or vector. Another significant patent involves an eye drop composition for the prevention and treatment of ophthalmic diseases, which includes a fusion protein of FK506 binding protein that can penetrate ocular tissue effectively.

Career Highlights

Throughout his career, Dae Won Kim has worked with various organizations, including the Industry-Academic Cooperation Foundation at Hallym University and Genesen Co., Ltd. His work has been instrumental in advancing the field of pharmaceutical sciences, particularly in drug delivery mechanisms.

Collaborations

Dae Won Kim has collaborated with notable colleagues, including Sung Ho Lee and Won Sik Eum. Their combined expertise has contributed to the successful development of innovative pharmaceutical solutions.

Conclusion

Dae Won Kim's contributions to the field of pharmaceutical compositions highlight his role as a leading inventor in drug delivery systems. His innovative patents and collaborations continue to pave the way for advancements in medical treatments.